A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation
Abstract Two-cycle cesium chloride (2 × CsCl) gradient ultracentrifugation is a conventional approach for purifying recombinant adenoviruses (rAds) for research purposes (gene therapy, vaccines, and oncolytic vectors). However, rAds containing the RGD-4C peptide in the HI loop of the fiber knob doma...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/10edaa59e24f4ba993cb64ff48bcec17 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:10edaa59e24f4ba993cb64ff48bcec17 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:10edaa59e24f4ba993cb64ff48bcec172021-12-02T19:06:40ZA new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation10.1038/s41598-021-94573-y2045-2322https://doaj.org/article/10edaa59e24f4ba993cb64ff48bcec172021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94573-yhttps://doaj.org/toc/2045-2322Abstract Two-cycle cesium chloride (2 × CsCl) gradient ultracentrifugation is a conventional approach for purifying recombinant adenoviruses (rAds) for research purposes (gene therapy, vaccines, and oncolytic vectors). However, rAds containing the RGD-4C peptide in the HI loop of the fiber knob domain tend to aggregate during 2 × CsCl gradient ultracentrifugation resulting in a low infectious titer yield or even purification failure. An iodixanol-based purification method preventing aggregation of the RGD4C-modified rAds has been proposed. However, the reason explaining aggregation of the RGD4C-modified rAds during 2 × CsCl but not iodixanol gradient ultracentrifugation has not been revealed. In the present study, we showed that rAds with the RGD-4C peptide in the HI loop but not at the C-terminus of the fiber knob domain were prone to aggregate during 2 × CsCl but not iodixanol gradient ultracentrifugation. The cysteine residues with free thiol groups after the RGD motif within the inserted RGD-4C peptide were responsible for formation of the interparticle disulfide bonds under atmospheric oxygen and aggregation of Ad5-delta-24-RGD4C-based rAds during 2 × CsCl gradient ultracentrifugation, which could be prevented using iodixanol gradient ultracentrifugation, most likely due to antioxidant properties of iodixanol. A cysteine-to-glycine substitution of the cysteine residues with free thiol groups (RGD-2C2G) prevented aggregation during 2 × CsCl gradient purification but in coxsackie and adenovirus receptor (CAR)-low/negative cancer cell lines of human and rodent origin, this reduced cytolytic efficacy to the levels observed for a fiber non-modified control vector. However, both Ad5-delta-24-RGD4C and Ad5-delta-24-RGD2C2G were equally effective in the murine immunocompetent CT-2A glioma model due to a primary role of antitumor immune responses in the therapeutic efficacy of oncolytic virotherapy.Aleksei A. StepanenkoAnastasiia O. SosnovtsevaMarat P. ValikhovVladimir P. ChekhoninNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-15 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Aleksei A. Stepanenko Anastasiia O. Sosnovtseva Marat P. Valikhov Vladimir P. Chekhonin A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation |
description |
Abstract Two-cycle cesium chloride (2 × CsCl) gradient ultracentrifugation is a conventional approach for purifying recombinant adenoviruses (rAds) for research purposes (gene therapy, vaccines, and oncolytic vectors). However, rAds containing the RGD-4C peptide in the HI loop of the fiber knob domain tend to aggregate during 2 × CsCl gradient ultracentrifugation resulting in a low infectious titer yield or even purification failure. An iodixanol-based purification method preventing aggregation of the RGD4C-modified rAds has been proposed. However, the reason explaining aggregation of the RGD4C-modified rAds during 2 × CsCl but not iodixanol gradient ultracentrifugation has not been revealed. In the present study, we showed that rAds with the RGD-4C peptide in the HI loop but not at the C-terminus of the fiber knob domain were prone to aggregate during 2 × CsCl but not iodixanol gradient ultracentrifugation. The cysteine residues with free thiol groups after the RGD motif within the inserted RGD-4C peptide were responsible for formation of the interparticle disulfide bonds under atmospheric oxygen and aggregation of Ad5-delta-24-RGD4C-based rAds during 2 × CsCl gradient ultracentrifugation, which could be prevented using iodixanol gradient ultracentrifugation, most likely due to antioxidant properties of iodixanol. A cysteine-to-glycine substitution of the cysteine residues with free thiol groups (RGD-2C2G) prevented aggregation during 2 × CsCl gradient purification but in coxsackie and adenovirus receptor (CAR)-low/negative cancer cell lines of human and rodent origin, this reduced cytolytic efficacy to the levels observed for a fiber non-modified control vector. However, both Ad5-delta-24-RGD4C and Ad5-delta-24-RGD2C2G were equally effective in the murine immunocompetent CT-2A glioma model due to a primary role of antitumor immune responses in the therapeutic efficacy of oncolytic virotherapy. |
format |
article |
author |
Aleksei A. Stepanenko Anastasiia O. Sosnovtseva Marat P. Valikhov Vladimir P. Chekhonin |
author_facet |
Aleksei A. Stepanenko Anastasiia O. Sosnovtseva Marat P. Valikhov Vladimir P. Chekhonin |
author_sort |
Aleksei A. Stepanenko |
title |
A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation |
title_short |
A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation |
title_full |
A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation |
title_fullStr |
A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation |
title_full_unstemmed |
A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation |
title_sort |
new insight into aggregation of oncolytic adenovirus ad5-delta-24-rgd during cscl gradient ultracentrifugation |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/10edaa59e24f4ba993cb64ff48bcec17 |
work_keys_str_mv |
AT alekseiastepanenko anewinsightintoaggregationofoncolyticadenovirusad5delta24rgdduringcsclgradientultracentrifugation AT anastasiiaososnovtseva anewinsightintoaggregationofoncolyticadenovirusad5delta24rgdduringcsclgradientultracentrifugation AT maratpvalikhov anewinsightintoaggregationofoncolyticadenovirusad5delta24rgdduringcsclgradientultracentrifugation AT vladimirpchekhonin anewinsightintoaggregationofoncolyticadenovirusad5delta24rgdduringcsclgradientultracentrifugation AT alekseiastepanenko newinsightintoaggregationofoncolyticadenovirusad5delta24rgdduringcsclgradientultracentrifugation AT anastasiiaososnovtseva newinsightintoaggregationofoncolyticadenovirusad5delta24rgdduringcsclgradientultracentrifugation AT maratpvalikhov newinsightintoaggregationofoncolyticadenovirusad5delta24rgdduringcsclgradientultracentrifugation AT vladimirpchekhonin newinsightintoaggregationofoncolyticadenovirusad5delta24rgdduringcsclgradientultracentrifugation |
_version_ |
1718377131653726208 |